Status of Stem Cell Based Clinical Trials in the Treatment for Diabetes

ISSN: 1875-6417 (Online)
ISSN: 1573-3998 (Print)

Volume 13, 6 Issues, 2017

Download PDF Flyer

Current Diabetes Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Norman E. Cameron
University of Aberdeen
Aberdeen, Scotland

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Status of Stem Cell Based Clinical Trials in the Treatment for Diabetes

Current Diabetes Reviews, 9(6): 429-436.

Author(s): Chandra Viswanathan and Shabari Sarang.

Affiliation: Reliance Life Sciences Pvt Ltd., Dhirubhai Ambani Life Sciences Centre, R/282, MIDC area of TTC, Thane Belapur Road, Rabale, Navi Mumbai 400701, India


Rapidly increasing number of diabetic patients across the world is a great challenge to the current therapeutic approach. Although the traditional method of rendering exogenous insulin is an established method of treatment, it is not sufficient and often causes lethal hypoglycemia. There is also a good amount of success with whole organ transplantation or Islet cells’ transplantation. But this technique is limited with regards the availability of donors. Currently, many clinicians and researchers are involved in clinical studies using various different stem cells from embryonic as well as adult sources for the treatment of diabetes. In this review we have tried to discuss the results of various clinical trials using stem cells. We have also tried to look at various stem cell types and the routes of injections that are currently being followed world wide.


Clinical trials, diabetes, stem cells, mesenchymal stem cells.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 6
First Page: 429
Last Page: 436
Page Count: 8
DOI: 10.2174/15733998113096660082
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science